ID: ALA32768

Max Phase: Preclinical

Molecular Formula: C14H26ClN3O2

Molecular Weight: 268.38

Molecule Type: Small molecule

Representations

Canonical SMILES:  CCCCCCCCOC[n+]1ccn(C)c1/C=N/O.[Cl-]

Standard InChI:  InChI=1S/C14H25N3O2.ClH/c1-3-4-5-6-7-8-11-19-13-17-10-9-16(2)14(17)12-15-18;/h9-10,12H,3-8,11,13H2,1-2H3;1H

Standard InChI Key:  VMGTVVBGSTUZRH-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 268.38

Molecular Weight (Monoisotopic): 268.2020

AlogP: 2.46

#Rotatable Bonds: 10

Polar Surface Area: 50.63

Molecular Species: NEUTRAL

HBA: 4

HBD: 1

#RO5 Violations: 0

HBA (Lipinski): 5

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 7.04

CX Basic pKa:

CX LogP: -0.40

CX LogD: -0.85

Aromatic Rings: 1

Heavy Atoms: 19

QED Weighted: 0.23

Np Likeness Score: 0.00

References

1. Bedford CD, Harris RN, Howd RA, Miller A, Nolen HW, Kenley RA..  (1984)  Structure-activity relationships for reactivators of organophosphorus-inhibited acetylcholinesterase: quaternary salts of 2-[(hydroxyimino)methyl]imidazole.,  27  (11): [PMID:6492073] [10.1021/jm00377a010]

2. Bedford CD, Harris RN, Howd RA, Goff DA, Koolpe GA, Petesch M, Miller A, Nolen HW, Musallam HA, Pick RO..  (1989)  Quaternary salts of 2-[(hydroxyimino)methyl]imidazole. 2. Preparation and in vitro and in vivo evaluation of 1-(alkoxymethyl)-2-[(hydroxyimino)methyl]-3-methylimida zolium halides for reactivation of organophosphorus-inhibited acetylcholinesterases.,  32  (2): [PMID:2913310] [10.1021/jm00122a034]

Source

Source(1):

• Scientific Literature